Evidence map›Paper›PMID 31979374›Full record

ReviewInternational journal of molecular sciences2020

Alessandro Gambella, Rebecca Senetta, Giammarco Collemi, Stefano Gabriele Vallero, Matteo Monticelli, Fabio Cofano, Pietro Zeppa, Diego Garbossa, Alessia Pellerino, Roberta Rudà and 5 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. JCO precision oncology · 2026
    Review
  7. Review
  8. Adult Low-Grade Glioma WithCase reports in pathology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. The Role of RAS in CNS Tumors: A Key Player or an Overlooked Oncogene?International journal of molecular sciences · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Alessandro GambellaPathology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Rebecca SenettaPathology Unit, Department of Oncology, University of Turin, 10126 Turin, Italy.
Giammarco CollemiPathology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Stefano Gabriele ValleroPediatric Onco-Hematology Unit, Department of Pediatric and Public Health Sciences, University of Turin, 10126 Turin, Italy.
Matteo MonticelliNeurosurgery Unit, Department of Neurosciences, University of Turin, 10126 Turin, Italy.
Fabio CofanoNeurosurgery Unit, Department of Neurosciences, University of Turin, 10126 Turin, Italy.
Pietro ZeppaNeurosurgery Unit, Department of Neurosciences, University of Turin, 10126 Turin, Italy.
Diego GarbossaNeurosurgery Unit, Department of Neurosciences, University of Turin, 10126 Turin, Italy.
Alessia PellerinoDepartment of Neuro-Oncology, University and City of Health and Science Hospital, 10126 Turin, Italy.
Roberta RudàDepartment of Neuro-Oncology, University and City of Health and Science Hospital, 10126 Turin, Italy.
Riccardo SoffiettiDepartment of Neuro-Oncology, University and City of Health and Science Hospital, 10126 Turin, Italy.
Franca FagioliPediatric Onco-Hematology Unit, Department of Pediatric and Public Health Sciences, University of Turin, 10126 Turin, Italy.
Mauro PapottiPathology Unit, Department of Oncology, University of Turin, 10126 Turin, Italy.
Paola CassoniPathology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Luca BerteroPathology Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
University of Turin · ITPiedmont Reference Center for Epidemiology and Cancer Prevention · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca - MIUR D15D18000410001Rete Oncologica del Piemonte e della Valle d'Aosta not available
6 · The paper itself

Abstract

The neurotrophic tropomyosin receptor kinase (

Indexed as

Gene FusionAnimalsBiomarkers, TumorCentral Nervous System NeoplasmsHumansMembrane GlycoproteinsPrecision MedicineProtein Kinase InhibitorsReceptor, trkAReceptor, trkBReceptor, trkCSignal TransductionBiomarkers, TumorMembrane GlycoproteinsProtein Kinase InhibitorsReceptor, trkAReceptor, trkBReceptor, trkCtropomyosin-related kinase-B, humancentral nervous systemgene fusiongliomamolecular pathologyNTRKpediatric tumorsprecision medicinetargeted therapies

Identifiers

PMID31979374
PMCPMC7037946
OpenAlexW3001529224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.